FDA clearance for the additional large sizes enables NPseal to be used for dressing of closed surgical incisions in orthopaedic, caesarean, and cardiothoracic procedures. Credit: Peter Porrini / Shutterstock.

Privately held company Guard Medical has announced the US Food and Drug Administration (FDA) 510(k) clearance for additional large sizes of its negative pressure wound therapy (NPWT) dressing, NPseal.

 The clearance covers surgical wounds up to 25cm, potentially unlocking the orthopaedic market for the company.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Recognised for its ease of use, affordability, and cost-effectiveness, NPseal features an integrated pump that establishes and maintains negative pressure with minimal effort. Guard Medical announced in February 2022 the completion of the NPseal post-market study at Keck Medical Center of USC.

Englewood Orthopedic Associates senior partner and chief of orthopaedic surgery Asit Shah commented on the development: “Following the successful clinical results of NPseal with my hip replacement patients, the additional large sizes will expand the use of NPseal to all our patients including knee replacement patients. I look forward to dressing my patients’ wounds for success with NPseal.”

Guard Medical CEO Machiel van der Leest expressed enthusiasm about the expansion: “We’re excited to expand our portfolio with the NPseal 20 and NPseal 25. FDA clearance for the additional large sizes allows NPseal to become the dressing of choice for the treatment of closed surgical incisions in orthopaedic, cesarean, and cardiothoracic procedures.

“We believe that NPseal uniquely fits in the ever-increasing outpatient trend requiring higher patient mobility and self-care.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company aims to address the limitations of conventional disposable NPWT devices, which have been restricted in their widespread use due to high costs and complexity.

NPseal dressings are designed to broaden the application of NPWT while propelling conversion from the advanced wound dressing and standard dressing markets.

Guard Medical’s NPWT technology originated with New York-Presbyterian and Weill Cornell Medicine, responding to the need for better solutions to prevent surgical site infections (SSI).

The company’s current investors include Bpifrance and Matignon Investissement et Gestion, with a vision to develop NPWT solutions applicable across various surgical wound types and sizes, aiming for broad applications in infection prevention, scar mitigation, and enhanced cosmesis.